Jason C. Chandler

miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

Anna M. Eiring, Jason G. Harb, Paolo Neviani et al. · Cell · 2010 · 561 citations · Full text

Genetics, Mrna Translation, Mir-328 Functions +9

Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

James L. Gulley, Arun Rajan, David R. Spigel et al. · The Lancet Oncology · 2017 · 283 citations · Full text

Oncology, Javelin Solid Tumor, Metronomic Therapy +9

Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

Shaji Kumar, Natalie S. Callander, Melissa Alsina et al. · Journal of the National Comprehensive Cancer Network · 2017 · 277 citations · Full text

Hematological Malignancy, Plasma Cells, Bone Marrow Failure +14

Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

Shaji Kumar, Natalie S. Callander, Kehinde Adekola et al. · Journal of the National Comprehensive Cancer Network · 2020 · 273 citations

Hematological Malignancy, Bone Marrow Failure, Medicine +10

Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation — Positive Advanced Non–Small Cell Lung Cancer (CheckMate 370)

David R. Spigel, Craig H. Reynolds, David Waterhouse et al. · Journal of Thoracic Oncology · 2018 · 223 citations

Phase 1/2, Medicine, Immunology +9